This inventor holds 1 USPTO granted patent. Top assignee: Hafslund Nycomed A/s. Active years: 1990.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1990
Title: Oyvind Skraastad: Innovator in Medical Treatment
Introduction
Oyvind Skraastad is a notable inventor based in Oslo, Norway. He has made significant contributions to the field of medical treatment, particularly in addressing lesions in the large intestinal epithelium. His innovative approach has the potential to impact many lives positively.
Latest Patents
Oyvind Skraastad holds a patent for a method aimed at treating hyperproliferative benign or malignant lesions in the large intestinal epithelium. The method involves administering the tripeptide L-pyroglutamyl-L-histidyl-glycine, which is designed to provide effective treatment options for patients suffering from these conditions. He has 1 patent to his name.
Career Highlights
Throughout his career, Oyvind has worked with Hafslund Nycomed A/S, where he has been able to apply his expertise in medical innovations. His work has been instrumental in developing new treatment methodologies that enhance patient care.
Collaborations
Oyvind has collaborated with esteemed colleagues such as Paul D. Edminson and Karl Ludwig Reichelt. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Oyvind Skraastad is a dedicated inventor whose work in medical treatment showcases his commitment to improving healthcare. His innovative methods and collaborations highlight the importance of teamwork in advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile